Physicochemical Properties
| Molecular Formula | C17H14FN3O2 |
| Molecular Weight | 311.310367107391 |
| Exact Mass | 311.107 |
| CAS # | 2682114-39-0 |
| PubChem CID | 146019721 |
| Appearance | Light yellow to light brown solid powder |
| LogP | 2.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 23 |
| Complexity | 423 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C(N)(=O)C1=CC=C(C2N(C)N=CC=2)C=C1OC1=CC=CC=C1F |
| InChi Key | MFSSHRCJKRDIOL-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C17H14FN3O2/c1-21-14(8-9-20-21)11-6-7-12(17(19)22)16(10-11)23-15-5-3-2-4-13(15)18/h2-10H,1H3,(H2,19,22) |
| Chemical Name | 2-(2-fluorophenoxy)-4-(2-methylpyrazol-3-yl)benzamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | RIN1 suppresses the growth of blood cancer cell lines and stimulates skeletal muscle development from C2C12 myoblasts [1]. RIN1 (0.6 μM, equivalent to 3 times IC50) has been shown to cause the production of multinucleated myofibers because it decreases the number of MHC+ cells and increases the number of nuclei per cell [1]. |
| Cell Assay |
Cell Viability Assay[1] Cell Types: AD-293 cells were transfected with RBPJ-VP16myc. Tested Concentrations: 2 μM. Incubation Duration: 17 hrs (hours). Experimental Results: Inhibited Hes1-Luciferase activity with an IC50 of 0.18 µM and Emax of 82%. Inhibited NOTCH3 ICD with similar potency and efcacy (0.19 µM and Emax=88%). Cell Proliferation Assay[1] Cell Types: T-cell acute lymphoblastic leukemia (T-ALL) patients (Jurkat and KOPT-K1) and in the mantle cell lymphoma (MCL) line REC-1. Tested Concentrations: 0.1-10 μM. Incubation Duration: 96 h. Experimental Results: Inhibited NOTCH-dependent tumor cell proliferation. Was active in both the cancer cell anti-proliferation and myoblast diferentiation assays. |
| References |
[1]. Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ. Sci Rep. 2019 Jul 25;9(1):10811. |
Solubility Data
| Solubility (In Vitro) | DMSO: 250 mg/mL (803.06 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (6.68 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (6.68 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (6.68 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.2122 mL | 16.0612 mL | 32.1223 mL | |
| 5 mM | 0.6424 mL | 3.2122 mL | 6.4245 mL | |
| 10 mM | 0.3212 mL | 1.6061 mL | 3.2122 mL |